Tekcapital PLC · LSE:TEK

Tekcapital — Investor Presentation (December 2021)

25 slides from Tekcapital's investor presentation, December 2021

  1. Slide 1: Building Valuable Companies with University Discoveries

    BUILDING VALUABLE COMPANIES WITH UNIVERSITY DISCOVERIES INVESTOR PRESENTATION December 2021 AIM:TEK, OTCQB: TEKCF © 2021 Tekcapital plc Tekcapital.com

  2. Slide 2: Important Notice

    IMPORTANT NOTICE By accepting this document, and in consideration for it being made available to such recipient, each attempt to deal in a qualifying investment or related investment (as defined in MAR) on the basis of the recipient agrees to keep strictly confidential the information contained in i

  3. Slide 3: Transforming University Discoveries into Valuable New Products

    TRANSFORMING UNIVERSITY DISCOVERIES INTO VALUABLE NEW PRODUCTS Building portfolio Providing Multi-year track companies with technology record of significant university technology transfer services growth of net assets coupled with star power for 250+ leading and returns on management universities in

  4. Slide 4: Latest Financial Results H1 May 2021

    LATEST FINANCIAL RESULTS H1 31 MAY 2021 Objective Growth of Net Assets from commercializing university discoveries that can improve quality of life. Performance • Net assets increased 56% to $51.1m (30 Nov 2020: $32.7m) - NAV per share $0.39 (30 Nov 2020: $0.35) - Increase in NAV largely due to ROIC

  5. Slide 5: Tekcapital's Invention Discovery Network

    TEKCAPITAL’S INVENTION DISCOVERY NETWORK We have visibility to the world’s university-developed IP from 4,500 research institutions. This mitigates adverse selection and provides continuous acquisition opportunities. 5 5

  6. Slide 6: Portfolio Companies

    PORTFOLIO COMPANIES PERCENTAGE OWNERSHIP & BOOK VALUE at 30 JUNE 2021 Ownership: 15% BV H1 2021: $12.8m Ownership: 100%** BV H1 2021: $7.9m Ownership: 100%** BV H1 2021: $22m Ownership: 97.2%** BV H1 2021: $3.6m * Salarius Ltd owns 87.1% of MicroSalt Inc, its U.S. based subsidiary. ** Lucyd Ltd owns

  7. Slide 7: Premium Medical Devices at Value Prices X-PLO2R Portable Oxygen Concentrator

    Premium Medical Devices at Value Prices X-PLO2R™ Portable Oxygen Concentrator • Medical device company developing innovative oxygen therapy products. • 3 September 2021 X-PLO2R™ commercially launched . production and delivery to customers • 24 May 2021 Belluscura announcd its IPO on AIM at 45 pence

  8. Slide 8: Share Price Performance Post IPO

    SHARE PRICE PERFOMANCE POST IPO STOCK CHART 28 MAY 2021 THROUGH 9 DECEMBER 2021 Tekcapital owns 17.1m shares of Belluscura plc. Value of Holding at H1 2021: $12.8m Value of Holding at 9 December 2021: $27.87m 8 8

  9. Slide 9: Lucyd: the clear choice for smart eyewear

    Lucyd: the clear choice for smart eyewear • Goal: Upgrade your Eyewear®. Develop a successful global smart eyewear brand for prescription and sunglasses for all-day wear. • 13 Dec 2021 Innovative Eyewear files S1 registration statement for an IPO in the U.S. and intends to list on Nasdaq under ticke

  10. Slide 10: Chris Clark PGA Golfer & Lucyd Brand Ambassador

    Chris Clark PGA Golfer & Lucyd Brand Ambassador 10 10

  11. Slide 11: Patented Low-sodium salt (MicroSalt)

    Patented Low-sodium salt (MicroSalt®) • Salarius aims to make a dent in cardiovascular disease by providing the best, great tasting low-sodium salt that is all natural, non-GMO and Kosher • Goal: Become the leading , all natural, low-sodium salt supplier • 18 Nov. 2021 MicroSalt, Inc. has won an awa

  12. Slide 12: International Awards (2021) for the Best Low Sodium Salt

    INTERNATIONAL AWARDS (2021) FOR THE BEST LOW SODIUM SALT microsaltinc.com

  13. Slide 13: Dr. Jay Shah, Medical Advisor to MicroSalt

    Dr. Jay Shah, cardiologist at Mayo Clinic & Medical Advisor to MicroSalt Play Video 13 13

  14. Slide 14: Successful and Experienced Board

    Successful and Experienced Board Salarius appointed Salarius appointed Eduardo Souchon as a Steve McCready as a director. Eduardo has 20 director. Steve served years of business, brand as Director of Product and marketing experience Development at focused on snacks (Brand Albertson’s Companies, mana

  15. Slide 15: Software to enhance safety & efficiency of autonomous vehicles

    Software to enhance safety & efficiency of autonomous vehicles & ground-based delivery devices • Goal: Provide managed software solutions for autonomous vehicle manufacturers and operators to enhance their safety. Guident is building a remote monitoring and control center (RMCC) for AV’s in Florida

  16. Slide 16: Regenerative Shock Absorber Engineering Simulation

    Regenrative Shock Absorber Engineering Simulation for New Prototype Design (Prototype fabrication underway) 16 16

  17. Slide 17: Successful and Experienced Team

    Successful and Experienced Team Guident appointed Guident appointed Johan Harald Braun as its CEO & De Nysschen as a director. Chairman. Mr. Braun has Johanis serves as COO of Volkswagen USAand served as CEO of Siemens previously served as Networks USA (NYSE: SI) Executive Vice President and Aviat N

  18. Slide 18: Summary

    SUMMARY Tekcapital commercialises university innovations for its own 1 portfolio and as a service for university clients We have built a high-value portfolio consisting of Belluscura, Lucyd, Salarius, & 2 Guident, all with exciting near-term growth prospects Tekcapital has a multi-year track record

  19. Slide 19: Appendix

    -@- TEKCAPITAL APPENDIX

  20. Slide 20: Directors

    DIRECTORS Clifford Gross, Ph.D., Chairman Cliff is passionate about commercialisation of university discoveries to improve quality of life. He founded three companies (Biomechanics Corp., UTEK & Tekcapital) which subsequently listed, where he served as CEO and Chairman and co-founded numerous privat

  21. Slide 21: Advisors

    Advisors NOMAD & BROKER AUDITORS INVESTOR RELATIONS (U.K.) SP Angel Corporate MacIntyre Hudson LLP Flagstaff Strategic and Investor Finance LLP 6th Floor Communications Prince Frederick House 35- 2 London Wall Place 1 King Street 39 Maddox Street London EC2Y 5AU LONDON, EC2V 8AU LONDON, W1S 2PP +44(

  22. Slide 22: Partial Client List

    O®acvevra THERAPEUTICS” CSL $ PEPSICO EAtherspoutics _ tro de tr aS de Polimeros Avanzados YEdgewel . uv Duke University Medical Center cam innovate arkansas PARTIAL CLIENT LIST y, PREDICTIVE ‘os THERAPEUTICS A UNIVERSITY OF MINNESOTA \) EMORY UNIVERSITY GW UDD Universidad del Desarrollo uT™™M. COPE

  23. Slide 23: What Our Clients Say About Us

    WHAT OUR CLIENTS SAY ABOUT US “Tekcapital helps companies of all sizes find and acquire university discoveries to create market value. We have found their offering to be well received by our listed companies that have tried their service. “ 2016 $764,444 Paul Dorfman Managing Director $953,167 NYSE

  24. Slide 24: What Our Clients Say About Us

    WHAT OUR CLIENTS SAY ABOUT US “We have had a great experience with the results of the studies we have requested." Patricia Anguita, 2016 $764,444 SubGerente de Comercializacion de Proyectos de Innovacion en Foundacion COPEC-UC $953,167 “We would recommend Invention Evaluator reports to any organizat

  25. Slide 25: What the Press Says About Us

    WHAT THE PRESS SAYS ABOUT US “In addition to a growing portfolio of university IP investments, Tekcapital helps research institutions and businesses develop disruptive technologies and expand their portfolios of intellectual capital through leveraging their suite of powerful and convenient technolog

Tekcapital — Investor Presentation (December 2021) on 6ix